139 related articles for article (PubMed ID: 2947762)
1. The relationship of soluble immune complexes, insulin antibodies and insulin-anti-insulin complexes to platelet and coagulation factors in type 1 diabetic patients with and without proliferative retinopathy.
Di Mario U; Borsey DQ; Contreas G; Prowse CV; Clarke BF; Andreani D
Clin Exp Immunol; 1986 Jul; 65(1):57-65. PubMed ID: 2947762
[TBL] [Abstract][Full Text] [Related]
2. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
Roy MS; Podgor MJ; Rick ME
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
[TBL] [Abstract][Full Text] [Related]
3. The relationship of insulin antibodies, platelet-fixing immune complexes and platelet-associated IgG to in vitro platelet aggregation and thromboxane B2 synthesis in childhood type 1 (insulin-dependent) diabetes mellitus.
Triolo G; Davì G; Giardina E; Cardella F; Meli F; Strano A; Bompiani GD
Diabetes Res; 1989 Jan; 10(1):1-5. PubMed ID: 2503285
[TBL] [Abstract][Full Text] [Related]
4. Platelets, coagulation and fibrinolysis in patients with diabetic retinopathy.
Brooks AM; Hussein S; Chesterman CN; Martin JF; Alford FP; Penington DG
Thromb Haemost; 1983 Apr; 49(2):123-7. PubMed ID: 6223403
[TBL] [Abstract][Full Text] [Related]
5. [Anti-insulin antibodies and circulating immune complexes in patients with diabetes mellitus].
Efimov AS; Malyzhev VA; Sakalo EA
Ter Arkh; 1987; 59(11):15-8. PubMed ID: 3441859
[TBL] [Abstract][Full Text] [Related]
6. Platelet associated IgG (PA IgG) in patients with insulin dependent (type 1) diabetes mellitus.
Triolo G
J Clin Lab Immunol; 1988 Apr; 25(4):173-5. PubMed ID: 3172176
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes, insulin antibodies, and deposits of immunoglobulins in the skin in diabetes.
Josephsen PG; Permin H; Juhl F; Enk B; Svehag SE
Dan Med Bull; 1986 Jun; 33(3):171-4. PubMed ID: 3720367
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of IgA-IgG immune complexes and anti-F(ab')2 antibodies in patients with type 2 (non insulin-dependent) diabetes mellitus and microangiopathy.
Casiglia D; Giardina E; Scarantino G; Triolo G
Diabetes Res; 1990 Dec; 15(4):195-200. PubMed ID: 2132409
[TBL] [Abstract][Full Text] [Related]
9. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
Artery; 1980; 8(1):73-9. PubMed ID: 6158934
[TBL] [Abstract][Full Text] [Related]
10. Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy.
Watzke H; Schernthaner G; Schnack C; Schwarz HP; Prskavec F; Freyler H
Diabetes Res; 1988 Apr; 7(4):197-200. PubMed ID: 3402169
[TBL] [Abstract][Full Text] [Related]
11. Plasma factors and platelet aggregation in diabetes mellitus.
Colwell JA; Van Zile J; Kilpatrick JM; Nair RM; Virella G
Horm Metab Res Suppl; 1981; 11():1-6. PubMed ID: 6976300
[TBL] [Abstract][Full Text] [Related]
12. Platelet and coagulation factors in proliferative diabetic retinopathy.
Borsey DQ; Prowse CV; Gray RS; Dawes J; James K; Elton RA; Clarke BF
J Clin Pathol; 1984 Jun; 37(6):659-64. PubMed ID: 6202721
[TBL] [Abstract][Full Text] [Related]
13. Plasma fibronectin, factor VIII-related antigen and fibrinogen concentrations, and diabetic retinopathy.
Davis TM; Moore JC; Turner RC
Diabete Metab; 1985 Jun; 11(3):147-51. PubMed ID: 3928410
[TBL] [Abstract][Full Text] [Related]
14. Anti-insulin antibodies and retinopathy in juvenile onset type-1 diabetes.
Sharma K; Khosla PK; Tiwari HK; Sharma RK; Bajaj JS
Indian J Ophthalmol; 1991; 39(4):174-5. PubMed ID: 1810880
[TBL] [Abstract][Full Text] [Related]
15. Plasma prekallikrein as a risk factor for diabetic retinopathy.
Kedzierska K; Ciechanowski K; Gołembiewska E; Safranow K; Ciechanowicz A; Domański L; Myślak M; Róźański J
Arch Med Res; 2005; 36(5):539-43. PubMed ID: 16099335
[TBL] [Abstract][Full Text] [Related]
16. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
[TBL] [Abstract][Full Text] [Related]
17. [Impaired antiendotoxin immunity in patients with diabetic retinopathy and type 2 diabetes mellitus].
Zhaboedov GD; Kopaenko AI
Vestn Oftalmol; 2005; 121(6):29-31. PubMed ID: 16405060
[TBL] [Abstract][Full Text] [Related]
18. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
[TBL] [Abstract][Full Text] [Related]
19. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY
Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
[TBL] [Abstract][Full Text] [Related]
20. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
